Skip to content
★ Sign in to follow
PS

Paul Sauer

SVP, Développement des Processus
Total declarations
21
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€1.0M

Latest filing published 07 Sept 2022 for Vaxcyte, Inc., €23k.

Filing timeline

BuySale
Paul Sauer

Insider track record

Disclosed buys
0
Disclosed sells
15

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Paul Sauer: trading record in brief

Paul Sauer, listed as senior executive, appears in our data through filings on Vaxcyte, Inc. shares, published by SEC (Form 4). We count 21 filings; the first trade dates from 11 January 2021 and the latest from 2 September 2022.

Sales make up the whole of the open-market record (15 sales, €1.0M). The rest of the record consists of 2 share grants and 3 option exercises. Since January 2022: no purchases and 7 sales on the market.

On 7 September 2022 came the latest disclosure, a share grant for €23k in Vaxcyte, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Paul Sauer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◆
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    22,819 USD11SEC
    865 shares@ US$26.381.9% of flowCommon StockSEC:0001209191-22-049023:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    77,785 USD27SEC
    3,000 shares@ US$25.92836.4% of flowCommon StockSEC:0001209191-22-047354:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    75,000 USD27SEC
    3,000 shares@ US$25.006.0% of flowCommon StockSEC:0001209191-22-043547:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    75,000 USD27SEC
    3,000 shares@ US$25.006.0% of flowCommon StockSEC:0001209191-22-043024:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    78,671 USD24SEC
    3,000 shares@ US$26.22358.1% of flowCommon StockSEC:0001209191-22-031865:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    75,000 USD24SEC
    3,000 shares@ US$25.007.6% of flowCommon StockSEC:0001209191-22-025654:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    75,000 USD24SEC
    3,000 shares@ US$25.007.5% of flowCommon StockSEC:0001209191-22-020962:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    150,000 USD12SEC
    6,000 shares@ US$25.0014.9% of flowCommon StockSEC:0001209191-22-018522:0
  • ◆
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    0SEC
    10,000 shares0Common StockSEC:0001209191-22-016522:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    150,000 USD12SEC
    6,000 shares@ US$25.0014.6% of flowCommon StockSEC:0001209191-21-071604:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    75,000 USD12SEC
    3,000 shares@ US$25.007.2% of flowCommon StockSEC:0001209191-21-062762:0
  • ▼
    SVP Process Dev, ManufacturingExecutivesVaxcyte, Inc.
    133,724 USD12SEC
    5,307 shares@ US$25.197712.6% of flowCommon StockSEC:0001209191-21-057651:0

12 of 12 declarations